Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003919
Accepted
2024-12-27 00:15:06
Documents
1
Effectiveness Date
2024-12-26

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-24-003919.txt   1870
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283897 | Film No.: 241582132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)